Regel Therapeutics

Boston, United States

Regel Therapeutics provides gene therapy that significantly improve the lives of people with life-threatening genetic illnesses.

$1.0M raised

Sep 2023

Grant

Biotechnology Genetics Therapeutics

Top Investors

HS Chau Foundation

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Regel Therapeutics

How much funding has Regel Therapeutics raised?

Regel Therapeutics has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in September 2023.

Who are Regel Therapeutics's investors?

Regel Therapeutics's investors include HS Chau Foundation.

Where is Regel Therapeutics headquartered?

Regel Therapeutics is headquartered in Boston, United States.

What does Regel Therapeutics do?

Regel Therapeutics provides gene therapy that significantly improve the lives of people with life-threatening genetic illnesses.

What stage is Regel Therapeutics at?

Regel Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 29, 2023.

MLA

"Regel Therapeutics — Funding & Investors." VCBacked, September 29, 2023, https://www.vcbacked.co/company/regel-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Regel Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/regel-therapeutics

Wikipedia (cite web)

{{cite web |title=Regel Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/regel-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 29, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K